About KinoPharma

Kinopharma is a biopharmaceutical company engaged in the discovery and development of small molecule drugs inhibiting novel Ser/Thr kinases based on the proprietary platform technologies. Pipeline includes kinase inhibitors for virus infection and CNS disorders:

 1-1 DNA Virus Infection program (broad spectrum over HSV, CMV, HPV, adv)

 1-2 RNA Virus Infection program (broad spectrum over HCV, influenza)

 2. CNS Disorder program:  Down syndrome, Alzheimer's disease

Kinopharma was established in 2005 as an academic spin-off company and its research laboratories are located in Kyoto and Kobe, Japan.